{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:39:23Z","timestamp":1787585963212,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82174458"],"award-info":[{"award-number":["No. 82174458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National High Level Chinese Medicine Hospital Clinical Research Funding","award":["DFRCZY-2024GJRC017"],"award-info":[{"award-number":["DFRCZY-2024GJRC017"]}]},{"name":"The Sixth Batch of Beijing Municipal Chinese Medicine Experts' Academic Experience Inheritance Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14174-0","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T12:07:28Z","timestamp":1745669248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive pan-cancer analysis of CHRDL1 and experimental validation of its role in lung adenocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Guangyin","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangke","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuixiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"4","key":"14174_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3892\/mmr.2013.1310","volume":"7","author":"WL Gao","year":"2013","unstructured":"Gao WL, Zhang SQ, Zhang H, Wan B, Yin ZS. Chordin-like protein 1 promotes neuronal differentiation by inhibiting bone morphogenetic protein-4 in neural stem cells. Mol Med Rep. 2013;7(4):1143\u20138. https:\/\/doi.org\/10.3892\/mmr.2013.1310.","journal-title":"Mol Med Rep"},{"key":"14174_CR2","doi-asserted-by":"publisher","unstructured":"Liu D, Pu Z, Li B, Tan G, Xie T, Shen Y. Chrdl1-mediated BMP4 inhibition disrupts the balance between retinal neurons and M\u00fcller Glia.\u00a0Cell Death Discov. 2024;10(1):367. Published 2024 Aug 17. https:\/\/doi.org\/10.1038\/s41420-024-02129-6","DOI":"10.1038\/s41420-024-02129-6"},{"issue":"5","key":"14174_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1681\/ASN.2008070768","volume":"20","author":"BW Larman","year":"2009","unstructured":"Larman BW, Karolak MJ, Adams DC, Oxburgh L. Chordin-like 1 and twisted gastrulation 1 regulate BMP signaling following kidney injury. J Am Soc Nephrol. 2009;20(5):1020\u201331. https:\/\/doi.org\/10.1681\/ASN.2008070768.","journal-title":"J Am Soc Nephrol"},{"key":"14174_CR4","doi-asserted-by":"publisher","unstructured":"Ruozi G, Bortolotti F, Mura A, et al. Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library.\u00a0Sci Transl Med. 2022;14(660):eabo0699. https:\/\/doi.org\/10.1126\/scitranslmed.abo0699","DOI":"10.1126\/scitranslmed.abo0699"},{"issue":"6","key":"14174_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/mc.23711","volume":"63","author":"J Li","year":"2024","unstructured":"Li J, Jiang Z, He J, et al. Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF-\u03b2\/VEGF pathway. Mol Carcinog. 2024;63(6):1092\u2013105. https:\/\/doi.org\/10.1002\/mc.23711.","journal-title":"Mol Carcinog"},{"key":"14174_CR6","doi-asserted-by":"publisher","unstructured":"Pei YF, Zhang YJ, Lei Y, Wu WD, Ma TH, Liu XQ. Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer [published correction appears in Oncotarget. 2017;8(29):48526. https:\/\/doi.org\/10.18632\/oncotarget.19303. Wu, Ding-Wei [corrected to Wu, Wei-ding]].\u00a0Oncotarget. 2017;8(14):23155\u201323166. https:\/\/doi.org\/10.18632\/oncotarget.15513","DOI":"10.18632\/oncotarget.19303 10.18632\/oncotarget.15513"},{"key":"14174_CR7","doi-asserted-by":"publisher","unstructured":"Wu Q, Zheng Z, Zhang J, et al. Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis\u00a0via\u00a0the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma.\u00a0Front Oncol. 2022;12:862751. Published 2022 Apr 14. https:\/\/doi.org\/10.3389\/fonc.2022.862751","DOI":"10.3389\/fonc.2022.862751"},{"key":"14174_CR8","doi-asserted-by":"publisher","unstructured":"Cyr-Depauw C, Northey JJ, Tabari\u00e8s S, et al. Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.\u00a0Mol Cell Biol. 2016;36(10):1509\u201325. Published 2016 May 2. https:\/\/doi.org\/10.1128\/MCB.00600-15","DOI":"10.1128\/MCB.00600-15"},{"issue":"1","key":"14174_CR9","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1080\/21655979.2021.1940615","volume":"12","author":"Y Pan","year":"2021","unstructured":"Pan Y, Wu L, He S, Wu J, Wang T, Zang H. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis. Bioengineered. 2021;12(1):2928\u201340. https:\/\/doi.org\/10.1080\/21655979.2021.1940615.","journal-title":"Bioengineered"},{"key":"14174_CR10","doi-asserted-by":"publisher","unstructured":"Deng H, Hang Q, Shen D, Zhang Y, Chen M. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.\u00a0Cancer Cell Int. 2021;21(1):259. Published 2021 May 12. https:\/\/doi.org\/10.1186\/s12935-021-01933-9","DOI":"10.1186\/s12935-021-01933-9"},{"issue":"2","key":"14174_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/CBM-230028","volume":"38","author":"Z Su","year":"2023","unstructured":"Su Z, Wang G, Li L. CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer. Cancer Biomark. 2023;38(2):143\u201359. https:\/\/doi.org\/10.3233\/CBM-230028.","journal-title":"Cancer Biomark"},{"key":"14174_CR12","doi-asserted-by":"crossref","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, Zhu J, Haussler D. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138. XENA da leggere","DOI":"10.1038\/s41587-020-0546-8"},{"key":"14174_CR13","doi-asserted-by":"publisher","unstructured":"Shen W, Song Z, Zhong X, et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.\u00a0Imeta. 2022;1(3):e36. Published 2022 July 8. https:\/\/doi.org\/10.1002\/imt2.36","DOI":"10.1002\/imt2.36"},{"issue":"1","key":"14174_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"key":"14174_CR15","doi-asserted-by":"publisher","unstructured":"Zeng D, Ye Z, Shen R, et al. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.\u00a0Front Immunol. 2021;12:687975. Published 2021 July 2. https:\/\/doi.org\/10.3389\/fimmu.2021.687975","DOI":"10.3389\/fimmu.2021.687975"},{"key":"14174_CR16","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"issue":"2","key":"14174_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 2018;173(2):338-354.e15. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034.","journal-title":"Cell"},{"key":"14174_CR18","doi-asserted-by":"publisher","unstructured":"Ma D, Liu H, Qin Y, Tian Z, Li S, Liang N. KLF8 overexpression promotes the growth of human lung cancer cells by promoting the expression of JMJD2A.\u00a0Cancer Cell Int. 2019;19:258. Published 2019 Oct 7. https:\/\/doi.org\/10.1186\/s12935-019-0970-3","DOI":"10.1186\/s12935-019-0970-3"},{"issue":"W1","key":"14174_CR19","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360. https:\/\/doi.org\/10.1093\/nar\/gkz430.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"14174_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.18632\/aging.203814","volume":"14","author":"B Deng","year":"2022","unstructured":"Deng B, Chen X, Xu L, et al. Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma. Aging (Albany NY). 2022;14(1):389\u2013409. https:\/\/doi.org\/10.18632\/aging.203814.","journal-title":"Aging (Albany NY)"},{"key":"14174_CR21","doi-asserted-by":"publisher","unstructured":"Berglar I, Hehlgans S, Wehle A, et al. CHRDL1 Regulates Stemness in Glioma Stem-like Cells.\u00a0Cells. 2022;11(23):3917. Published 2022 Dec 3. https:\/\/doi.org\/10.3390\/cells11233917","DOI":"10.3390\/cells11233917"},{"issue":"17","key":"14174_CR22","doi-asserted-by":"publisher","first-page":"18050","DOI":"10.1002\/cam4.6411","volume":"12","author":"S Sahni","year":"2023","unstructured":"Sahni S, Nahm C, Ahadi MS, et al. Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy. Cancer Med. 2023;12(17):18050\u201361. https:\/\/doi.org\/10.1002\/cam4.6411.","journal-title":"Cancer Med"},{"key":"14174_CR23","doi-asserted-by":"publisher","unstructured":"Shen Y, Dong S, Liu J, et al. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.\u00a0Biomed Res Int. 2020;2020:9710421. Published 2020 Apr 1. https:\/\/doi.org\/10.1155\/2020\/9710421","DOI":"10.1155\/2020\/9710421"},{"key":"14174_CR24","doi-asserted-by":"publisher","unstructured":"Li H, Lei Y, Li G, Huang Y. Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses.\u00a0Oncol Res. 2023;32(1):187\u201397. Published 2023 Nov 15. https:\/\/doi.org\/10.32604\/or.2023.030656","DOI":"10.32604\/or.2023.030656"},{"key":"14174_CR25","doi-asserted-by":"publisher","unstructured":"Wang B, Hao X, Yan J, Li X, Zhao M, Han T. A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma.\u00a0J Transl Int Med. 2024;12(3):225\u201343. Published 2024 Jul 27. https:\/\/doi.org\/10.2478\/jtim-2024-0003","DOI":"10.2478\/jtim-2024-0003"},{"issue":"8","key":"14174_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807\u201321. https:\/\/doi.org\/10.1038\/s41423-020-0488-6.","journal-title":"Cell Mol Immunol"},{"key":"14174_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.semcancer.2019.12.018","volume":"72","author":"CN Baxevanis","year":"2021","unstructured":"Baxevanis CN, Fortis SP, Perez SA. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies. Semin Cancer Biol. 2021;72:76\u201389. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.018.","journal-title":"Semin Cancer Biol"},{"key":"14174_CR28","doi-asserted-by":"publisher","unstructured":"Jiang H, Awuti G, Guo X. Construction of an Immunophenoscore-Related Signature for Evaluating Prognosis and Immunotherapy Sensitivity in Ovarian Cancer.\u00a0ACS Omega. 2023;8(36):33017\u201331. Published 2023 Aug 30. https:\/\/doi.org\/10.1021\/acsomega.3c04856","DOI":"10.1021\/acsomega.3c04856"},{"key":"14174_CR29","doi-asserted-by":"publisher","first-page":"107985","DOI":"10.1016\/j.pharmthera.2021.107985","volume":"231","author":"R Paul","year":"2022","unstructured":"Paul R, Dorsey JF, Fan Y. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications. Pharmacol Ther. 2022;231:107985. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107985.","journal-title":"Pharmacol Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14174-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14174-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14174-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T12:07:30Z","timestamp":1745669250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14174-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14174"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14174-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Animal Ethics Committee of Dongfang Hospital, Beijing University of Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"783"}}